Viewing Study NCT06392659


Ignite Creation Date: 2025-12-24 @ 2:46 PM
Ignite Modification Date: 2026-01-06 @ 2:36 AM
Study NCT ID: NCT06392659
Status: COMPLETED
Last Update Posted: 2024-08-01
First Post: 2024-04-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1, Open-label Study Evaluating the Pharmacokinetics and Drug-drug Interaction of VX-993 in Healthy Adults
Sponsor: Vertex Pharmaceuticals Incorporated
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module